JPRN-jRCT2080223493已完成3 期
MJR-35 long-term study to investigate the safety and efficacy in patients with dysmenorrhea
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 147
研究概览
简要总结
This study showed favorable tolerability of the long-term use of MJR-35 to patients with dysmenorrhea and a sustainable pain relief effect.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •(1)Patients who have a painful symptom (lower abdominal pain or lumber pain) that were considered to be originated in dysmenorrhea in a degree of 3 points or more of dysmenorrhea score
- •(2)Patients diagnosed with dysmenorrhea
- •(3)Regular menstrual cycle length within 38 days
排除标准
- •(1)Patient with a complication of submucosal myoma
- •(2)Patients with a complication of lower abdominal pain or lumber pain which they can not judge whether due to dysmenorrhea or not
- •(3)Patients with a remarkable uterus swelling
- •(4)Patients with undiagnosed abnormal genital bleeding, endometrial polyp, uterine deformity or endometrial hyperplasia
- •(5)Patients with severe anemia
研究者
相似试验
已完成
3 期
MJR-35 Phase 3 StudyDysmenorrheaJPRN-jRCT2080223492MOCHIDA PHARMACEUTICAL CO., LTD.95
已完成
2 期
A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's DiseaseAlzheimer's DiseaseNCT02260674Janssen Research & Development, LLC114
未知
2 期
MJR-35 Phase 2 StudyFunctional DysmenorrheaJPRN-jRCT2080222925MOCHIDA PHARMACEUTICAL CO., LTD.225
终止
2 期
An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease SpectrumAlzheimer DiseaseNCT02406027Janssen Research & Development, LLC90
未知
3 期
MJR-35 Phase 3 StudyJPRN-jRCT2080222591MOCHIDA PHARMACEUTICAL CO., LTD.60